Free Trial

Atara Biotherapeutics (ATRA) SEC Filings & 10K Form

Atara Biotherapeutics logo
$5.84 -0.14 (-2.34%)
As of 04:00 PM Eastern

Recent Atara Biotherapeutics SEC Filings

DateFilerForm TypeView
04/10/2025
6:14 PM
Atara Biotherapeutics (Issuer)
Grant-Huerta Yanina (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2025
6:54 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:16 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:17 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:17 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
5:29 PM
Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
5:30 PM
Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
5:27 PM
Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2025
5:34 PM
Atara Biotherapeutics (Subject)
Panacea Innovation Ltd (Filed by)
Form SCHEDULE 13G
01/29/2025
3:52 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
6:36 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
3:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:00 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
5:04 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
5:04 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
5:05 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:54 PM
Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
4:55 PM
Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
4:56 PM
Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
4:58 PM
Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
5:10 PM
Atara Biotherapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
12:29 PM
Atara Biotherapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:24 AM
Atara Biotherapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/15/2024
3:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
4:03 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
5:42 PM
Adiumentum Capital Fund I GP LLC (Reporting)
Adiumentum Capital Fund I LP (Reporting)
Atara Biotherapeutics (Issuer)
Ciongoli Gregory Austin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2024
3:07 PM
Adiumentum Capital Fund I LP (Filed by)
Atara Biotherapeutics (Subject)
Form SC 13D/A
09/04/2024
3:42 PM
Atara Biotherapeutics (Filer)
Form 424B5
09/03/2024
4:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
5:26 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:27 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:27 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:27 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:27 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:10 PM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
4:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:16 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:32 PM
Atara Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
06/20/2024
4:04 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
06/17/2024
7:30 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
5:18 PM
Adiumentum Capital Fund I LP (Filed by)
Atara Biotherapeutics (Subject)
Form SC 13D
05/20/2024
7:32 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:33 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:33 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:34 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:34 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
8:13 PM
Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
8:13 PM
Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
8:14 PM
Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
8:14 PM
Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
8:15 PM
Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
7:55 PM
Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/26/2024
3:20 PM
Atara Biotherapeutics (Filer)
Form DEFA14A
04/26/2024
3:15 PM
Atara Biotherapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ATRA) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners